Skip to main content
Log in

Primärprävention des Peniskarzinoms

Nutzen der HPV-Impfung und Zirkumzision

Prevention of penile cancer

Value of the HPV vaccination and circumcision

  • Leitthema
  • Published:
Der Urologe Aims and scope Submit manuscript

Zusammenfassung

Das Peniskarzinom gehört zu den seltenen Tumoren. Peniskarzinome entstehen nahezu ausschließlich bei nicht zirkumzidierten Männern. Außerdem ist ein Großteil der Peniskarzinome HPV-assoziiert. Die vorliegende Arbeit beschäftigt sich mit der Wertigkeit von Zirkumzision und der HPV- (Human-papillomavirus-)Impfung in der Prävention von Peniskarzinomen.

Abstract

Penile cancer is rare. Penile cancers appear predominantly in non-circumcised men. In addition, the majority of penile cancers are associated with human papillomavirus infection. The present manuscript is concerned with the value of circumcision and HPV vaccination in the prevention of penile cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Daling JR, Madeleine MM, Johnson LG et al. (2005) Penile cancer: importance of circumcision, human papillomavirus and smoking in in situ and invasive disease. Int J Cancer 116: 606–616

    Article  PubMed  Google Scholar 

  2. Rippentrop JM, Joslyn SA, Konety BR (2004) Squamous cell carcinoma of the penis evaluation of data from the surveillance, epidemiology, and end results program. Cancer 101: 1357–1363

    Article  PubMed  Google Scholar 

  3. Kochen M, McCurdy S (1980) Circumcision and the risk of cancer of the penis: a life-table analysis. Am J Dis Child 134: 484–486

    PubMed  Google Scholar 

  4. Schoen EJ (1991) The relationship between circumcision and cancer of the penis. CA Cancer J Clin 41: 306–309

    PubMed  Google Scholar 

  5. Preston EN (1970) Whither the foreskin? A consideration of routine neonatal circumcision. JAMA 213: 1853–1858

    Article  PubMed  Google Scholar 

  6. Task force on circumcision (1999) Circumcision policy statement. Pediatrics 103: 686–693

    Article  PubMed  Google Scholar 

  7. Singh-Grewal D, Macdessi J, Craig J (2005) Circumcision for the prevention of urinary tract infection in boys: a systematic review of randomised trials and observational studies. Arch Dis Child 90: 853–858

    Article  PubMed  Google Scholar 

  8. Fergusson DM, Boden JM, Horwood LJ (2006) Circumcision status and risk of sexually transmitted infection in young adult males: an analysis of a longitudinal birth cohort. Pediatrics 118: 1971–1977

    Article  PubMed  Google Scholar 

  9. Gray RH, Kigozi G, Serwadda D et al. (2007) Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. Lancet 369: 657–666

    Article  PubMed  Google Scholar 

  10. Cupp MR, Malek RS, Goellner JR et al. (1995) The detection of human papillomavirus deoxyribonucleic acid in intraepithelial, in situ, verrucous and invasive carcinoma of the penis. J Urol 154: 1024–1029

    Article  PubMed  Google Scholar 

  11. Sarkar FH, Miles BJ, Plieth DH, Crissman JD (1992) Detection of human papillomavirus in squamous neoplasm of the penis. J Urol 147: 389–392

    PubMed  Google Scholar 

  12. Bezerra AL, Lopes A, Santiago GH et al. (2001) Human papillomavirus as a prognostic factor in carcinoma of the penis: analysis of 82 patients treated with amputation and bilateral lymphadenectomy. Cancer 91: 2315–2321

    Article  PubMed  Google Scholar 

  13. Wiener JS, Effert PJ, Humphrey PA et al. (1992) Prevalence of human papillomavirus types 16 and 18 in squamous-cell carcinoma of the penis: a retrospective analysis of primary and metastatic lesions by differential polymerase chain reaction. Int J Cancer 50: 694–701

    Article  PubMed  Google Scholar 

  14. Gregoire L, Cubilla AL, Reuter VE et al. (1995) Preferential association of human papillomavirus with highgrade histologic variants of penile-invasive squamous cell carcinoma. J Natl Cancer Inst 87: 1705–1709

    Article  PubMed  Google Scholar 

  15. Gross G (2006) HPV-Vakzine: Wer sollte wann, wo und wie geimpft werden? Dtsch Arztebl A 103: 3384

    Google Scholar 

  16. Parkin DM, Bray F, Ferlay J, Pisani P (2001) Estimating the world cancer burden: Globocan 2000. Int J Cancer 94: 153–156

    Article  PubMed  Google Scholar 

  17. Munoz N, Bosch FX, Sanjose S de et al. (2003); International Agency for Research on Cancer Multicenter Cervical Cancer Study Group. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Eng J Med 348: 518–527

    Article  Google Scholar 

Download references

Interessenkonflikt

Keine Angaben

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A. Manseck.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Manseck, A. Primärprävention des Peniskarzinoms. Urologe 46, 646–650 (2007). https://doi.org/10.1007/s00120-007-1350-5

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00120-007-1350-5

Schlüsselwörter

Keywords

Navigation